Published in Arthritis Rheum on November 01, 1999
Teriparatide for Joint Erosions in Rheumatoid Arthritis: The TERA Trial (TERA) | NCT01400516
2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ (2002) 9.89
Glucocorticoid-induced osteoporosis: pathophysiology and therapy. Osteoporos Int (2007) 3.12
Superiority of alfacalcidol over plain vitamin D in the treatment of glucocorticoid-induced osteoporosis. Rheumatol Int (2003) 2.07
Extraintestinal manifestations and complications in inflammatory bowel diseases. World J Gastroenterol (2006) 1.73
Practice patterns in patients at risk for glucocorticoid-induced osteoporosis. Osteoporos Int (2005) 1.68
Positive effect of alendronate on bone mineral density and markers of bone turnover in patients with rheumatoid arthritis on chronic treatment with low-dose prednisone: a randomized, double-blind, placebo-controlled trial. Osteoporos Int (2006) 1.55
Tolerability and compliance with risedronate in clinical practice. Osteoporos Int (2003) 1.51
Risedronate for prevention of bone mineral density loss in patients receiving high-dose glucocorticoids: a randomized double-blind placebo-controlled trial. Osteoporos Int (2007) 1.44
Oral bisphosphonates reduce the risk of clinical fractures in glucocorticoid-induced osteoporosis in clinical practice. Osteoporos Int (2012) 1.42
A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy. Allergy Asthma Clin Immunol (2013) 1.40
A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis. Osteoporos Int (2012) 1.36
Glucocorticoid-induced bone loss in mice can be reversed by the actions of parathyroid hormone and risedronate on different pathways for bone formation and mineralization. Arthritis Rheum (2008) 1.33
Management of glucocorticoid-induced osteoporosis. Nat Rev Rheumatol (2010) 1.16
Basic and clinical aspects of osteoporosis in inflammatory bowel disease. World J Gastroenterol (2007) 1.12
Alendronate treatment of established primary osteoporosis in men: 3-year results of a prospective, comparative, two-arm study. Rheumatol Int (2003) 1.11
Prevention and treatment of systemic glucocorticoid side effects. Int J Dermatol (2010) 1.07
Advances in glucocorticoid-induced osteoporosis. Curr Rheumatol Rep (2011) 1.06
Bisphosphonates in osteoporosis. Eur Spine J (2003) 1.05
Reproducibility of bone mineral density measurement in daily practice. Ann Rheum Dis (2004) 1.05
Antiresorptive therapies for osteoporosis: a clinical overview. Nat Rev Endocrinol (2011) 1.04
Intermittent intravenous ibandronate injections reduce vertebral fracture risk in corticosteroid-induced osteoporosis: results from a long-term comparative study. Osteoporos Int (2003) 0.99
Evidence-based guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis: a consensus document of the Belgian Bone Club. Osteoporos Int (2005) 0.99
Teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: an analysis by gender and menopausal status. Osteoporos Int (2009) 0.94
Skeletal effects of short-term exposure to dexamethasone and response to risedronate treatment studied in vivo in rabbits by magnetic resonance micro-imaging and spectroscopy. J Bone Miner Metab (2006) 0.93
Risk factors for vertebral fracture in menopausal or postmenopausal Japanese women with rheumatoid arthritis: a cross-sectional and longitudinal study. J Bone Miner Metab (2006) 0.90
Biochemical assessment of bone turnover and bone fragility in men. Osteoporos Int (2007) 0.90
The role of bone biopsy in patients with chronic renal failure. Clin J Am Soc Nephrol (2008) 0.89
Prevalence and predictors of fragility fractures in systemic lupus erythematosus. Ann Rheum Dis (2005) 0.89
Bone fragility in male glucocorticoid-induced osteoporosis is not defined by bone mineral density. Osteoporos Int (2009) 0.87
Progress in osteoporosis and fracture prevention: focus on postmenopausal women. Arthritis Res Ther (2009) 0.85
Targeted treatment in COPD: a multi-system approach for a multi-system disease. Int J Chron Obstruct Pulmon Dis (2009) 0.85
Glucocorticoid-Induced Osteoporosis Program (GIOP): a novel, comprehensive, and highly successful care program with improved outcomes at 1 year. Osteoporos Int (2006) 0.83
Hepatic osteodystrophy. Clin Cases Miner Bone Metab (2014) 0.82
Glucocorticoid-induced osteoporosis: treatment update and review. Ther Adv Musculoskelet Dis (2009) 0.82
Prescription-event monitoring study on 13,164 patients prescribed risedronate in primary care in England. Osteoporos Int (2005) 0.82
Glucocorticoid-induced osteoporosis. RMD Open (2015) 0.82
Beneficial treatment with risedronate in long-term survivors after allogeneic stem cell transplantation for hematological malignancies. Osteoporos Int (2003) 0.82
Use of matched historical controls to evaluate the anti-fracture efficacy of once-a-week risedronate. Osteoporos Int (2003) 0.82
Guidelines on the management and treatment of glucocorticoid-induced osteoporosis of the Japanese Society for Bone and Mineral Research: 2014 update. J Bone Miner Metab (2014) 0.81
Effectiveness of alendronate and etidronate in the treatment of osteoporosis in men: a prospective observational study. Osteoporos Int (2005) 0.81
Bone loss in patients treated with pulses of methylprednisolone is not negligible: a short term prospective observational study. Ann Rheum Dis (2004) 0.81
Candida-associated gastric ulcer relapsing in a different position with a different appearance. World J Gastroenterol (2012) 0.80
Medical treatment of vertebral osteoporosis. Eur Spine J (2003) 0.80
Ibandronate increases cortical bone density in patients with systemic lupus erythematosus on long-term glucocorticoid. Arthritis Res Ther (2010) 0.80
Glucocorticosteroid-induced spinal osteoporosis: scientific update on pathophysiology and treatment. Eur Spine J (2006) 0.80
Recommendations for the registration of agents for prevention and treatment of glucocorticoid-induced osteoporosis: an update from the Group for the Respect of Ethics and Excellence in Science. Osteoporos Int (2008) 0.80
Current concepts for the management of systemic lupus erythematosus in adults: a therapeutic challenge. Postgrad Med J (2002) 0.80
Zoledronic acid versus alendronate for the prevention of bone loss after heart or liver transplantation. J Clin Endocrinol Metab (2012) 0.80
Longitudinal practice patterns of prophylaxis of glucocorticoid-induced osteoporosis in patients with polymyalgia rheumatica. Rheumatol Int (2014) 0.79
Post hoc analysis of a single IV infusion of zoledronic acid versus daily oral risedronate on lumbar spine bone mineral density in different subgroups with glucocorticoid-induced osteoporosis. Osteoporos Int (2012) 0.79
Glucocorticoid-induced osteoporosis - a disorder of mesenchymal stromal cells? Front Endocrinol (Lausanne) (2011) 0.79
Prevention and treatment strategies for glucocorticoid-induced osteoporotic fractures. Clin Rheumatol (2006) 0.78
Updates on mechanism of action and clinical efficacy of risedronate in osteoporosis. Clin Cases Miner Bone Metab (2014) 0.78
Glucocorticoid-induced osteoporosis: how best to avoid fractures. Ther Adv Chronic Dis (2010) 0.78
Effects of alendronate on bone mineral density and bone metabolic markers in patients with liver transplantation. Osteoporos Int (2006) 0.78
Advances in the management of corticosteroid-induced osteoporosis with bisphosphonates. Clin Rheumatol (2006) 0.78
Review of the safety and efficacy of risedronate for the treatment of male osteoporosis. Clin Interv Aging (2007) 0.78
Zoledronic Acid for the treatment and prevention of primary and secondary osteoporosis. Ther Adv Musculoskelet Dis (2010) 0.78
Multidetector-row computed tomography is useful to evaluate the therapeutic effects of bisphosphonates in glucocorticoid-induced osteoporosis. J Bone Miner Metab (2013) 0.77
Access to bone densitometry increases general practitioners' prescribing for osteoporosis in steroid treated patients. Ann Rheum Dis (2004) 0.77
Comparative Efficacy of Bisphosphonates to Prevent Fracture in Men with Osteoporosis: A Systematic Review with Network Meta-Analyses. Rheumatol Ther (2016) 0.77
Efficacy and safety of zoledronic acid in the treatment of glucocorticoid-induced osteoporosis. Ther Clin Risk Manag (2010) 0.77
Efficacy of osteoporosis pharmacotherapies in preventing fracture among oral glucocorticoid users: a network meta-analysis. Osteoporos Int (2016) 0.77
Prevention and treatment of corticosteroid-induced osteoporosis. Yonsei Med J (2005) 0.77
Fracture risk in oral glucocorticoid users: a Bayesian meta-regression leveraging control arms of osteoporosis clinical trials. Osteoporos Int (2015) 0.77
Treatment of glucocorticoid-induced osteoporsis. Ther Adv Musculoskelet Dis (2009) 0.76
Time Related Changes of Mineral and Collagen and Their Roles in Cortical Bone Mechanics of Ovariectomized Rabbits. PLoS One (2015) 0.76
Management of glucocorticoid-induced osteoporosis: prevalence, and emerging treatment options. Drug Healthc Patient Saf (2010) 0.76
Very high frequency of fragility fractures associated with high-dose glucocorticoids in postmenopausal women: A retrospective study. Bone Rep (2016) 0.75
One-year effects of glucocorticoids on bone density: a meta-analysis in cohorts on high and low-dose therapy. RMD Open (2016) 0.75
Relationship between bone mineral density and the frequent administration of epidural steroid injections in postmenopausal women with low back pain. Pain Res Manag (2014) 0.75
Combined oral administration of bovine collagen peptides with calcium citrate inhibits bone loss in ovariectomized rats. PLoS One (2015) 0.75
A Novel Hybrid Compound LLP2A-Ale Both Prevented and Rescued the Osteoporotic Phenotype in a Mouse Model of Glucocorticoid-Induced Osteoporosis. Calcif Tissue Int (2016) 0.75
Adverse bone effects of medications used to treat non-skeletal disorders. Osteoporos Int (2017) 0.75
Short-term glucocorticoid treatment causes spinal osteoporosis in ovariectomized rats. Eur Spine J (2014) 0.75
Prescription for antiresorptive therapy in Mexican patients with rheumatoid arthritis: is it time to reevaluate the strategies for osteoporosis prevention? Rheumatol Int (2012) 0.75
The complete genome of the hyperthermophilic bacterium Aquifex aeolicus. Nature (1998) 7.77
Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila. Nature (2001) 6.76
Neurological manifestations of the acquired immunodeficiency syndrome (AIDS): experience at UCSF and review of the literature. J Neurosurg (1985) 5.91
Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission. Effect of maternal zidovudine treatment on viral load. JAMA (1996) 4.33
The clinical and metabolic effects of porcine calcitonin on Paget's disease of bone. J Clin Invest (1971) 4.32
Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis. N Engl J Med (1997) 4.18
The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription. Proc Natl Acad Sci U S A (2000) 4.01
Effects of oral administration of type II collagen on rheumatoid arthritis. Science (1993) 3.32
Neuropsychiatric manifestations of systemic lupus erythematosus: diagnosis, clinical spectrum, and relationship to other features of the disease. Medicine (Baltimore) (1976) 3.07
Fractionation and identification of spinach chloroplast transfer RNAs and mapping of their genes on the restriction map of chloroplast DNA. Gene (1979) 2.82
Rapidly cycling affective disorder. Demographics, diagnosis, family history, and course. Arch Gen Psychiatry (1992) 2.78
Antibodies to type II collagen in relapsing polychondritis. N Engl J Med (1978) 2.65
Natural history of optic pathway tumors in children with neurofibromatosis type 1: a longitudinal study. J Pediatr (1994) 2.63
The enduring psychosocial consequences of mania and depression. Am J Psychiatry (1993) 2.45
Biodiversity meets the atmosphere: a global view of forest canopies. Science (2003) 2.38
Hair concentrations of nicotine and cotinine in women and their newborn infants. JAMA (1994) 2.18
Effect of anisotropy and anharmonicity on protein crystallographic refinement. An evaluation by molecular dynamics. J Mol Biol (1986) 2.16
Central nervous system mass lesions in the acquired immunodeficiency syndrome (AIDS). J Neurosurg (1984) 2.15
Factors predictive of maternal-fetal transmission of HIV-1. Preliminary analysis of zidovudine given during pregnancy and/or delivery. JAMA (1994) 2.14
Switching from 'unipolar' to bipolar II. An 11-year prospective study of clinical and temperamental predictors in 559 patients. Arch Gen Psychiatry (1995) 2.11
Ferroglobus placidus gen. nov., sp. nov., A novel hyperthermophilic archaeum that oxidizes Fe2+ at neutral pH under anoxic conditions. Arch Microbiol (1996) 2.06
Tenfold errors in administration of drug doses: a neglected iatrogenic disease in pediatrics. Pediatrics (1986) 2.01
Pyomyositis. Increasing recognition in temperate climates. Am J Med (1984) 1.92
Simplified amino acid alphabets for protein fold recognition and implications for folding. Protein Eng (2000) 1.91
Short leader sequences may be transferred from small RNAs to pre-mature mRNAs by trans-splicing in Euglena. EMBO J (1991) 1.85
Rituximab inhibits structural joint damage in patients with rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitor therapies. Ann Rheum Dis (2008) 1.84
Ca2+ dependence of tension and ADP production in segments of chemically skinned muscle fibers. Biochim Biophys Acta (1976) 1.75
[German S3-guideline "Diagnosis and treatment of esophagogastric cancer"]. Z Gastroenterol (2011) 1.74
The pseudothrombophlebitis syndrome. Medicine (Baltimore) (1977) 1.71
Effect of combined risedronate and hormone replacement therapies on bone mineral density in postmenopausal women. J Clin Endocrinol Metab (2001) 1.70
Identification and analysis of the Rhizobium meliloti exoAMONP genes involved in exopolysaccharide biosynthesis and mapping of promoters located on the exoHKLAMONP fragment. Mol Gen Genet (1993) 1.70
The 32-kilobase exp gene cluster of Rhizobium meliloti directing the biosynthesis of galactoglucan: genetic organization and properties of the encoded gene products. J Bacteriol (1997) 1.68
Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE study. Ann Rheum Dis (2005) 1.66
Quasi-harmonic method for studying very low frequency modes in proteins. Biopolymers (1984) 1.64
Determination of gestational cocaine exposure by hair analysis. JAMA (1989) 1.63
Effects of risedronate treatment on bone density and vertebral fracture in patients on corticosteroid therapy. Calcif Tissue Int (2000) 1.62
The efficacy and tolerability of risedronate once a week for the treatment of postmenopausal osteoporosis. Calcif Tissue Int (2002) 1.61
Seven years of treatment with risedronate in women with postmenopausal osteoporosis. Calcif Tissue Int (2004) 1.60
Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomized, double-blind, placebo-controlled extension trial. Arthritis Rheum (2001) 1.58
alpha-Helix dipole model and electrostatic stabilization of 4-alpha-helical proteins. Proc Natl Acad Sci U S A (1982) 1.57
The entry of antiviral and antiretroviral drugs into the central nervous system. J Neurovirol (1997) 1.56
Manic-depressive (bipolar) disorder: the course in light of a prospective ten-year follow-up of 131 patients. Acta Psychiatr Scand (1994) 1.54
Emergence of optic pathway gliomas in children with neurofibromatosis type 1 after normal neuroimaging results. J Pediatr (1992) 1.51
Regenerative therapies in neonatology: clinical perspectives. Klin Padiatr (2012) 1.49
Association of T-786C eNOS gene polymorphism with increased susceptibility to acute chest syndrome in females with sickle cell disease. Br J Haematol (2004) 1.48
Neurologic disturbances in Paget disease of bone: response to calcitonin. Neurology (1979) 1.48
Effect of three years of oral alendronate treatment in postmenopausal women with osteoporosis. Am J Med (1996) 1.46
Corticosteroid therapy associated with ischemic necrosis of bone in systemic lupus erythematosus. Am J Med (1985) 1.45
Response of Paget's disease to porcine and salmon calcitonins: effects of long-term treatment. Am J Med (1974) 1.44
Predictive factors for prolonged survival in acquired immunodeficiency syndrome-associated progressive multifocal leukoencephalopathy. Ann Neurol (1998) 1.43
A single ion as a nanoscopic probe of an optical field. Nature (2001) 1.42
Intravenous pulsed steroids in rheumatoid arthritis: a comparative dose study. J Rheumatol (1990) 1.42
Quality of life after restorative proctocolectomy and ileal pouch-anal anastomosis in patients with familial adenomatous polyposis: a matter of adjustment. Colorectal Dis (2011) 1.42
The arthropathy of Behçet's disease. Johns Hopkins Med J (1975) 1.41
Genetic analysis of the Rhizobium meliloti exoYFQ operon: ExoY is homologous to sugar transferases and ExoQ represents a transmembrane protein. Mol Plant Microbe Interact (1993) 1.41
Neuroradiologic findings in AIDS: a review of 200 cases. AJR Am J Roentgenol (1986) 1.39
Is the fetal brain-sparing effect a risk factor for the development of intraventricular hemorrhage in the preterm infant? Ultrasound Obstet Gynecol (1996) 1.39
Fatigue, serum cytokine levels, and blood cell counts during radiotherapy of patients with breast cancer. Int J Radiat Oncol Biol Phys (2001) 1.38
Early prognostic indicators in primary perinatal human immunodeficiency virus type 1 infection: importance of viral RNA and the timing of transmission on long-term outcome. J Infect Dis (1998) 1.37
Absolute and relative deficit in total-skeletal calcium and radial bone mineral in osteoporosis. J Nucl Med (1974) 1.35
Acute abdominal complications of systemic lupus erythematosus and polyarteritis nodosa. Am J Med (1982) 1.34
Treatment of hypertrophic obstructive cardiomyopathy with verapamil. Br Heart J (1979) 1.34
Intrinsic pKas of ionizable residues in proteins: an explicit solvent calculation for lysozyme. Proteins (1994) 1.34
Importance of psychotic features to long-term course in major depressive disorder. Am J Psychiatry (1996) 1.33
Psychological problems of cancer patients: a cancer distress screening with a cancer-specific questionnaire. Br J Cancer (2004) 1.32
Correlation of computed tomography findings and serum brain damage markers following severe head injury. Acta Neurochir (Wien) (1998) 1.32
Consistent N-myc copy number in simultaneous or consecutive neuroblastoma samples from sixty individual patients. Cancer Res (1987) 1.31
Prolonged estrogen therapy in postmenopausal women. J Am Med Assoc (1959) 1.30
Double-blind trial of recombinant gamma-interferon versus placebo in the treatment of rheumatoid arthritis. Arthritis Rheum (1989) 1.30
Alternative lengthening of telomeres is associated with chromosomal instability in osteosarcomas. Oncogene (2001) 1.29
Reactions depending on iron sulfide and linking geochemistry with biochemistry. Proc Natl Acad Sci U S A (1992) 1.28
Follow-up and family study of anxious depression. Am J Psychiatry (1991) 1.26
Low dose prednisone therapy in rheumatoid arthritis: a double blind study. J Rheumatol (1983) 1.25
Bipolar II illness: course and outcome over a five-year period. Psychol Med (1989) 1.24
Changes in blood hormone levels during the immune response. Proc Soc Exp Biol Med (1975) 1.23
Pharmacokinetics and safety of nelfinavir when used in combination with zidovudine and lamivudine in HIV-infected pregnant women: Pediatric AIDS Clinical Trials Group (PACTG) Protocol 353. HIV Clin Trials (2008) 1.22
Hypercalcemia in mycobacterial infection. J Clin Endocrinol Metab (1972) 1.22
Fulminant liver failure after vancomycin in a sulfasalazine-induced DRESS syndrome: fatal recurrence after liver transplantation. Am J Transplant (2009) 1.21
Optic pathway tumors in children: the effect of neurofibromatosis type 1 on clinical manifestations and natural history. J Pediatr (1995) 1.20
A medicinal extract of Scutellaria baicalensis and Acacia catechu acts as a dual inhibitor of cyclooxygenase and 5-lipoxygenase to reduce inflammation. J Med Food (2007) 1.19
The genetic organization and evolution of the broad host range mercury resistance plasmid pSB102 isolated from a microbial population residing in the rhizosphere of alfalfa. Nucleic Acids Res (2001) 1.19
Neuroimaging of cerebellar liponeurocytoma. Case report. J Neurosurg (2001) 1.19
Evaluation of specific value of endoscopic biopsies and brush cytology for malignancies of the oesophagus and stomach. Gut (1976) 1.18
A synthetic cryIC gene, encoding a Bacillus thuringiensis delta-endotoxin, confers Spodoptera resistance in alfalfa and tobacco. Proc Natl Acad Sci U S A (1996) 1.17
Iterative sequence/secondary structure search for protein homologs: comparison with amino acid sequence alignments and application to fold recognition in genome databases. Bioinformatics (2000) 1.17
Olfactory regulation of maternal behavior in mammals. Horm Behav (2004) 1.15
OA1 mutations and deletions in X-linked ocular albinism. Am J Hum Genet (1998) 1.15
Analysis of the Rhizobium meliloti genes exoU, exoV, exoW, exoT, and exoI involved in exopolysaccharide biosynthesis and nodule invasion: exoU and exoW probably encode glucosyltransferases. Mol Plant Microbe Interact (1994) 1.15
Effect of bone density information on decisions about hormone replacement therapy: a randomized trial. Obstet Gynecol (1997) 1.15
Aphid transmission of cauliflower mosaic virus requires the viral PIII protein. EMBO J (1999) 1.15
Molecular dynamics simulation of solvated protein at high pressure. Biochemistry (1992) 1.14
Prevalence of fetal exposure to cocaine in Toronto, 1990-1991. Clin Invest Med (1994) 1.14
Sustained efficacy and safety of bazedoxifene in preventing fractures in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled study. Osteoporos Int (2011) 1.13
A family study of bipolar II disorder. Br J Psychiatry (1984) 1.13
Primary central nervous system lymphomas: natural history and response to radiation therapy in 55 patients with acquired immunodeficiency syndrome. J Neurosurg (1990) 1.13
Neurosurgical implications of the acquired immunodeficiency syndrome (AIDS). Clin Neurosurg (1988) 1.13
The cellular transport of calcium in rat liver. J Gen Physiol (1966) 1.11
Hypoparathyroidism. Clinical observations in 34 patients. Arch Intern Med (1967) 1.11